December 14, 2021, Vol 326, No. 22, Pages 2239-2339
Pediatric COVID-19 Vaccines What Parents, Practitioners, and Policy Makers Need to Know
William J. Moss, MD, MPH; Lawrence O. Gostin, JD; Jennifer B. Nuzzo, DrPH, SM
JAMA. 2021;326(22):2257-2258. doi:10.1001/jama.2021.20734
This Viewpoint discusses the Food and Drug Administration granting Emergency Use Authorization of the mRNA COVID-19 vaccine BNT162b2 for children aged 5 to 11 years and the role that will play in keeping children, schools, and communities safe.